Sigma-Aldrich
MUPIROCIN (C005B-453475)
General description Mupirocin is produced by Pseudomonas fluorescens . It exhibits bacteriostatic action.
General description
Mupirocin is produced by Pseudomonas fluorescens. It exhibits bacteriostatic action. Mupirocin is used to treat impetigo and skin infections.
Application
Mupirocin has been used:
- for kinetic assay
- to assess its resistance by performing turbidity assay
- to determine its antimicrobial susceptibility
Biochem/physiol Actions
Antibiotic; inhibits isoleucyl-tRNA synthetase (IRS).
Features and Benefits
This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Specifications
- UPC:
- 51286501
- Condition:
- New
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- Quantity:
- 100
- Unit of Measurement:
- MG
- MPN:
- M7694-100MG
- CAS:
- 12650-69-0
- Controlled Substances and Cyanide:
- Yes



